Chlorhexidine resistance and the lipids of Providencia stuartii

Microbios
|January 1, 1979
PubMed

Insights

Providencia stuartii strains resistant to chlorhexidine antiseptic showed no differences in lipid content compared to sensitive strains. Resistance is not due to reduced antiseptic absorption or degradation.

Area of Science:

  • Microbiology
  • Antimicrobial Resistance

Background:

  • Providencia stuartii shares lipid similarities with Proteus mirabilis.
  • Some strains of P. stuartii exhibit resistance to high chlorhexidine concentrations.

Purpose of the Study:

  • To investigate the mechanisms behind chlorhexidine resistance in Providencia stuartii.
  • To determine if lipid composition differences explain antiseptic resistance.

Main Methods:

  • Comparative analysis of lipid content between sensitive and resistant strains.
  • Assessment of chlorhexidine adsorption to bacterial cells.
  • Evaluation of antiseptic enzymic degradation by bacterial strains.

Main Results:

  • No significant differences in lipid composition were found between chlorhexidine-sensitive and resistant P. stuartii strains.
  • Reduced adsorption of chlorhexidine to resistant strains was not observed.
  • Gross enzymic degradation of chlorhexidine by resistant strains was not evident.

Conclusions:

  • Lipid content differences do not explain chlorhexidine resistance in P. stuartii.
  • Resistance is not mediated by reduced antiseptic uptake or enzymatic breakdown.

Related Concept Videos

Biosynthesis of Lipids01:29

Biosynthesis of Lipids

Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...